Antileishmanial activity of Polyalthia longifolia leaf extract on the in vitro growth of Leishmania donovani promastigotes

Global Journal of Pharmacology

Volumn 5, Issue 2, 2011, Pages 97-100

  Pal, Dipayan ^a   Bhattacharya, Sanjib ^b   Baidya, Prasenjit ^a   De, Bijay K ^a   Pandey, J N ^a,b   Biswas, Moulisha ^a  

^a Bengal Institute of Pharmaceutical Sciences   (India)

^b Bengal School of Technology   (India)

Author keywords

Antileishmanial; Leishmania donovani; Polyalthia longifolia; Promastigotes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTILEISHMANIAL AGENT; METHANOL; PLANT EXTRACT; POLYALTHIA LONGIFOLIA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANNONACEAE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; GROWTH INHIBITION; IC 50; IN VITRO STUDY; LEISHMANIA DONOVANI; MICROBIAL GROWTH; NONHUMAN; PLANT LEAF; POLYALTHIA LONGIFOLIA; PROMASTIGOTE;

EID: 80052672718     PISSN: 19920075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anonymous, 2008. Report of the consultative meeting on cutaneous leishmaniasis. Geneva: World Health Organization.
2. Desjeux, P., 2001. The increase in the risk factors for leishmaniasis worldwide. Trans Royal Soc. Trop. Med. Hyg., 95: 239.
3. Handman, E., 2001. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev., 14:229-243.
4. Chappuis, F, S. Sundar, A. Hailu, H. Ghahb, S. Rijal, R.W. Peeling, J. Alvar andM. Boelaert, 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control. Nat. Rev. Microbiol., 5: 873.
5. Berman, J.D., 1996. Treatment of new world cutaneous and mucosal leishmaniases. Clin Dermatol., 14: 519-522.
6. Berman, J.D., 1997. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis., 24: 684-703.
7. Ephros, M., E. Waldman and D. Zilberstein, 1997. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrob. Agents Chemother., 41: 1064-1068.
8. Lira, R., S. Sundar, A. Makharia, R. Kenney, A. Gam, E. Saraiva and D. Sacks, 1999. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J. Infect Dis., 180: 564-567.
9. Boelaert, M., D. Leray and S.P. Vander, 2002. How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. Trop Med lnt Hlth., 7: 955-959.
10. Laguna, F., 2003. Treatment of leishmaniasis in HIV-positive patients. Ann Trop Med Parasitol., 91: S135.
11. Raghunathan, K. and M.K. Mitra, 1982. Pharmacognosy of Indigenous Drugs. Vol. I. NewDelhi: Central Council for Research in Ayurveda and Siddha, pp: 127.
12. Kirtikar, K.R. and B.D. Basu, 1998. Indian Medicinal Plants. Vol. I, Allahabad, India: Universal Book Distributors, pp: 72.
13. Rosakutty, P.J., A.S. Roslin and S. Ignacimuthu, 2000. Ethanobotany and Medicinal Plants of Indian Subcontinent. Jodhpur, India: Scientific Publishers, pp: 369.
14. Singh, V. and R.P. Pandey, 1998. Ethanobotany of Rajasthan. Jodhpur, India: Scientific Publishers, pp: 175.
15. Harborne, IB., 1998. Phytochemical methods, A Guide to Modern Techniques of Plant Analysis. New Delhi: Springer (India) Pvt. Ltd.
16. Ghosh, A.K., M.M. Rakshit and D.K. Ghosh, 1983. Effect of berberin chloride onLeishmania donovani. Ind J Medicinal Res., 78: 407-411.
17. Wright, C.W. and J.D. Philhpson, 1990. Natural products and the development of selective antiprotozoal drugs. Phytother Res., 4: 127-39.
18. Sereno, D. and L.L. Lemesre, 1997. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother., 41: 972-976.
19. Gupta, N., N. Goyal and A.K. Rastogi, 2001. In vitro cultivation and characterization of axenic amastigotes of Leishmania. Trends Parasitol., 17: 150-153.
20. Cowan, M.M., 1999. Plant products as antimicrobial agents. Clin Microbiol. Rev., 12: 564-582.
21. Hamburger, M. andK. Hostettmann, 1991. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry, 30: 3864-3874.